American Journal of Kidney Diseases
Volume 41 , Pages 11-17 , June 2003

Cardiovascular complications in chronic kidney disease

  • Mark J Sarnak, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Mark J. Sarnak, MD, Tufts-New England Medical Center, Box 391, Division of Nephrology, New England Medical Center, 750 Washington St, Boston, MA 02111, USA
    • Division of Nephrology, Tufts New England Medical Center, Boston, MA, USA

References 

  1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799–805
  2. Foley RN, Parfrey PS, Sarnak MJ. Cardiovascular disease in chronic renal disease (Clinical epidemiology of cardiovascular disease in chronic renal disease). Am J Kidney Dis. 1998;32(suppl 3):S112–S119
  3. Shulman NB, Ford CE, Hall WD, et al.  Hypertension Detection and Follow-Up Program Cooperative Group   Prognostic value of serum creatinine and effect of treatment of hypertension on renal function (Results from the Hypertension Detection and Follow-up Program). Hypertension. 1989;13(suppl I):SI80–SI93
  4. Wright RS, Reeder GS, Herzog CA, et al.  Acute myocardial infarction and renal dysfunction (A high-risk combination). Ann Intern Med. 2002;137:563–570
  5. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555–562
  6. Schunkert H, Hense HW. A heart price to pay for anaemia. Nephrol Dial Transplant. 2001;16:445–448
  7. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease (Insights from coronary angiography). Kidney Int. 1984;25:653–659
  8. Schwarz U, Buzello M, Ritz E, et al.  Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218–223
  9. London GM, Marchais SJ, Guerin AP, et al.  Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant. 2002;17:1713–1724
  10. Klassen PS, Lowrie EG, Reddan DN, et al.  Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548–1555
  11. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease (A new paradigm). Am J Kidney Dis. 2000;35(suppl 1):S117–S131
  12. De Santo NG, Cirillo M, Perna A, et al.  The heart in uremia (Role of hypertension, hypotension, and sleep apnea). Am J Kidney Dis. 2001;38(suppl 1):S38–S46
  13. Metivier F, Marchais SJ, Guerin AP, et al.  Pathophysiology of anaemia (Focus on the heart and blood vessels). Nephrol Dial Transplant. 2000;15(suppl 3):S14–S18
  14. Foley RN, Parfrey PS, Harnett JD, et al.  The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61
  15. Levin A, Thompson CR, Ethier J, et al.  Left ventricular mass index increase in early renal disease (Impact of decline in hemoglobin). Am J Kidney Dis. 1999;34:125–134
  16. Besarab A, Bolton WK, Nissenson AR, et al.  The Normal Haematocrit Trial in dialysis patients with cardiac disease. Nephrol Dial Transplant. 1999;14:2043–2044
  17. Foley RN, Parfrey PS, Morgan J, et al.  Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int. 2000;58:1325–1335
  18. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients (A national study). Am J Kidney Dis. 1998;31:607–617
  19. Braun J, Oldendorf M, Moshage W, et al.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394–401
  20. Goodman WG, Goldin J, Kuizon BD, et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  21. Raggi P, Boulay A, Chasan-Taber S, et al.  Cardiac calcification in adult hemodialysis patients (A link between end-stage renal disease and cardiovascular disease?). J Am Coll Cardiol. 2002;39:695–701
  22. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014–1021
  23. Blacher J, Guerin AP, Pannier B, et al.  Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  24. Blacher J, Guerin AP, Pannier B, et al.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938–942
  25. Chertow GM, Burke SK, Raggi P  Treat to Goal Working Group . Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–252
  26. Canavese C, Bergamo D, Dib H, Bermond F, Burdese M. Calcium on trial (Beyond a reasonable doubt?). Kidney Int. 2003;63:381–382 (letter)

☆ Supported by an unrestricted educational grant from Watson Pharma, Inc.

PII: S0272-6386(03)00372-X

doi: 10.1016/S0272-6386(03)00372-X

American Journal of Kidney Diseases
Volume 41 , Pages 11-17 , June 2003

Article Tools

* Image Usage & Resolution